KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $0 | -100.0% | 456 | -98.3% | 0.00% | – |
Q1 2022 | $37,000 | +15.6% | 26,556 | +0.3% | 0.00% | – |
Q4 2021 | $32,000 | -54.3% | 26,473 | -0.6% | 0.00% | – |
Q3 2021 | $70,000 | -50.0% | 26,635 | +0.8% | 0.00% | – |
Q2 2021 | $140,000 | -20.5% | 26,430 | +1.3% | 0.00% | – |
Q1 2021 | $176,000 | +13.5% | 26,100 | +14.0% | 0.00% | – |
Q4 2020 | $155,000 | -43.0% | 22,900 | -36.9% | 0.00% | – |
Q3 2020 | $272,000 | -28.8% | 36,300 | 0.0% | 0.00% | – |
Q2 2020 | $382,000 | +198.4% | 36,300 | +148.6% | 0.00% | – |
Q1 2020 | $128,000 | +137.0% | 14,600 | 0.0% | 0.00% | – |
Q4 2019 | $54,000 | -3.6% | 14,600 | 0.0% | 0.00% | – |
Q3 2019 | $56,000 | -39.8% | 14,600 | 0.0% | 0.00% | – |
Q2 2019 | $93,000 | -23.1% | 14,600 | 0.0% | 0.00% | – |
Q1 2019 | $121,000 | +70.4% | 14,600 | 0.0% | 0.00% | – |
Q4 2018 | $71,000 | -50.7% | 14,600 | 0.0% | 0.00% | – |
Q3 2018 | $144,000 | -28.0% | 14,600 | 0.0% | 0.00% | – |
Q2 2018 | $200,000 | -13.4% | 14,600 | 0.0% | 0.00% | – |
Q1 2018 | $231,000 | +66.2% | 14,600 | +94.7% | 0.00% | – |
Q4 2017 | $139,000 | – | 7,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parallel Advisors, LLC | 1 | $9 | 0.00% |